Akorn (AKRX) - 16 Year Stock Split History

Historical stock splits for Akorn since 2002. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Akorn Annual Stock Splits
Akorn Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.332B $0.841B
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $62.458B 10.72
Teva Pharmaceutical Industries (TEVA) Israel $22.859B 6.39
Mylan (MYL) United Kingdom $19.184B 8.16
Bausch Health Cos (BHC) Canada $7.619B 5.69
Dr Reddy's Laboratories (RDY) India $5.346B 23.88
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.588B 4.40
Supernus Pharmaceuticals (SUPN) United States $2.410B 25.78
Assembly Biosciences (ASMB) United States $1.006B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.801B 115.47
CymaBay Therapeutics (CBAY) United States $0.714B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.628B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.613B 0.00
Voyager Therapeutics (VYGR) United States $0.589B 0.00
Homology Medicines (FIXX) United States $0.582B 0.00
Corium (CORI) United States $0.314B 0.00
Teligent (TLGT) United States $0.220B 0.00
Sol-Gel Technologies (SLGL) Israel $0.124B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.115B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.073B 0.00
Versartis (VSAR) United States $0.063B 0.00
Aevi Genomic Medicine (GNMX) United States $0.058B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.023B 0.00
Acasti Pharma (ACST) Canada $0.019B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00
Agile Therapeutics (AGRX) United States $0.009B 0.00